Mechanism for activation of mutated epidermal growth factor receptors in lung cancer
Author:
Publisher
Proceedings of the National Academy of Sciences
Subject
Multidisciplinary
Reference40 articles.
1. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
2. Epidermal growth factor receptor mutations in lung cancer
3. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
4. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
5. Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer
Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Approximating Projections of Conformational Boltzmann Distributions with AlphaFold2 Predictions: Opportunities and Limitations;Journal of Chemical Theory and Computation;2024-01-12
2. Different EGF‐induced receptor dimer conformations for signaling and internalization;The FASEB Journal;2023-12-10
3. Detection of EGFR gene polymorphisms in non-small cell lung cancer Egyptian patients: a case–control study;Genes and Environment;2023-11-27
4. Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand binding;Nature Communications;2023-11-21
5. Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer;BioTech;2023-09-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3